Chimeric Antigen Receptor T-cell Therapies in Lymphoma Patients with Central Nervous System Involvement.

Hematology/oncology and stem cell therapy(2022)

引用 2|浏览4
暂无评分
摘要
Based on our PubMed literature review, we conclude that CAR T-cell therapy may benefit patients with CNS lymphoma with promising response rates and acceptable AE. However, definite conclusions cannot be drawn until data with a larger sample size is available.
更多
查看译文
关键词
lymphoma patients,chimeric antigen receptor,central nervous system,nervous system,t-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要